The University of Chicago Header Logo

Connection

Richard Larson to Blood Glucose

Back to Details
This is a "connection" page, showing publications Richard Larson has written about Blood Glucose.
Richard Larson
Connection Strength
0.022
Blood Glucose
  1. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. Leukemia. 2016 05; 30(5):1044-54.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.